Cytosorbents Corp Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Cytosorbents Corp (Nasdaq: CTSO) on June 1, 2022. The report addresses a change in the company's principal executive offices.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a corporate event and does not contain financial statements.
Material Changes
Effective June 1, 2022, the Company moved its headquarters and principal place of business to 305 College Road East, Princeton, New Jersey 08540. The former address was 7 Deer Park Drive, Suite K, Monmouth Junction, New Jersey 08852.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the address change.
Key Facts for Investors
- The company relocated its headquarters to Princeton, New Jersey, effective June 1, 2022.
- The filing contains no financial performance data or forward-looking guidance.
- The company remains listed on the Nasdaq Capital Market under the symbol CTSO.